# Marian Nakada

> Marian Nakada is a Series C investor at Women in VC backing Health Care and Therapeutics. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Women in VC](https://shizune.co/investors/profile/women-in-vc)
- Location: Cambridge, United States
- Total investments: 1
- Last investment: Mar 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/marian-nakada-ph-d-6624a01/
- X (Twitter): https://twitter.com/mnakada
- Website: https://x.com/mnakada

Marian Nakada is a Series C investor at Women in VC in Cambridge focused on Health Care and Therapeutics. Marian Nakada is based out of Cambridge, Massachusetts, and served as Vice President, Venture Investments of Johnson & Johnson Innovation. Marian previously worked at ONL Therapeutics as a Board Member. Marian Nakada attended Harvard University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ONL Therapeutics | ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. The current market for retinal drugs is greater than $7 billion and rapidly growing. Existing therapies have significant limitations and none address the initial neural component of vision loss - the death of the photoreceptorcell. | $15M | Series C | Mar 08, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Biosciences Research and Commercialization Center (BRCC)](https://shizune.co/investors/profile/biosciences-research-and-commercialization-center-brcc) — VC Fund, 1 deal together
- [Bios Partners](https://shizune.co/investors/profile/bios-partners) — VC Fund, 1 deal together
- [Capital Community Angel Investors](https://shizune.co/investors/profile/capital-community-angels-investors) — VC Fund, 1 deal together
- [ExSight Ventures](https://shizune.co/investors/profile/exsight-ventures) — VC Fund, 1 deal together
- [Kaitai Capital](https://shizune.co/investors/profile/kaitai-capital) — VC Fund, 1 deal together
- [Mayewell Capital](https://shizune.co/investors/profile/mayewell-capital) — VC Fund, 1 deal together

## About Women in VC

VC Fund · New York, United States

Women in VC is a global community for women in venture capital to connect, collaborate, and create opportunities. Its 3,000+ members, use its directory as a powerful tool to identify qualified co-investors, talent recruits, new connections on business trips, market diligence, and more. The directory is password protected and open to women employedfull-time at institutional, corporate, impact, accelerator, and family office funds making direct investments; applications are reviewed and approved on a rolling basis.The company was founded in 2015 and is based in New York, New York.

5 contacts available at Women in VC.

| Name | Title | Profile |
| --- | --- | --- |
| Alina Hoon | Member | https://shizune.co/investors/profile/alina-hoon |
| Grisel Hernandez | Member | https://shizune.co/investors/profile/grisel-hernandez-9bf5 |
| Holly Jacobus | Member | https://shizune.co/investors/profile/holly-jacobus |
| Jennifer Kan | Member | https://shizune.co/investors/profile/jennifer-kan-4be3 |
| Jessica Peltz-Zatulove | Co-Founder | https://shizune.co/investors/profile/jessica-peltz |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Marian Nakada invest in?

Marian Nakada invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Marian Nakada last invest?

The most recent investment recorded for Marian Nakada closed in Mar 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co